The risks of smoking and benefits of smoking cessation on hospitalisations for cardiovascular events and respiratory infection in patients with rheumatoid arthritis: a retrospective cohort study using the Clinical Practice Research Datalink

摘要

Objectives: To investigate the associations between smoking status, smoking cessation, and hospitalisations for cardiovascular events (CVE) and respiratory tract infections (RTI) in an inception cohort of patients with rheumatoid arthritis (RA).Methods: The study was set within UK primary care electronic health records (the Clinical Practice Research Datalink) linked to hospital inpatient data (Hospital Episode Statistics). Patients with RA were followed from diagnosis to hospitalisation with a record of CVE or RTI, leaving their general practice, death, or 10th January 2012, whichever was earliest. Smoking status (never, current, former) was defined using primary care data and could vary over time. Survival analysis was performed using Cox regression (first event) and conditional risk set models (multiple RTIs). Results:5677 patients were included in the cohort: 68% female, median age 61 years. The age-sex adjusted risks of hospitalisation for CVE or RTI were more than twice as high in current vs never smokers (CVE hazard ratio (95% confidence interval) 2.19 (1.44-3.31); RTI 2.18 (1.71-2.78)). The risks for both outcomes were significantly higher in current compared to former smokers (CVE 1.51 (1.04-2.19), RTI 1.29 (1.04-1.61)). For each additional year of smoking cessation, the risk of first CVE and RTI hospitalisation fell significantly, approximately 25% and 15% respectively in the adjusted models. Conclusions:RA patients who smoke have an increased risk of hospitalisation with CVE or RTI compared to never and former smokers. The risk decreases for each additional year of smoking cessation. Patients with RA who smoke should be advised to stop smoking.